טוען...
Screening for ALK abnormalities in central nervous system metastases of non‐small‐cell lung cancer
Anaplastic lymphoma kinase (ALK) gene rearrangement was reported in 3%–7% of primary non‐small‐cell lung cancer (NSCLC) and its presence is commonly associated with adenocarcinoma (AD) type and non‐smoking history. ALK tyrosine kinase inhibitors (TKIs) such as crizotinib, alectinib and ceritinib sho...
שמור ב:
| הוצא לאור ב: | Brain Pathol |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8028499/ https://ncbi.nlm.nih.gov/pubmed/27879019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12466 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|